Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Premature mortality due to cardiovascular disease (CVD) has decreased by 50% within a generation in several countries, a feat that…
The Indian Council of Medical Research (icmr) has recognized the Madras Diabetes Research Foundation (MDRF) as a Collaborating Centre of…
Mediterranean Diet May Lower Risk of Heart Diseases and Diabetes Mediterranean diet, renowned for its emphasis on fresh produce, whole…
NABH to Introduce Digital Standards for Cancer, Diabetes, and Maternal Care Across Hospitals nabh has announced a significant move to…
Diabetes and Heart Risks: A Guide to Safe Festive Feasting diabetes and heart conditions pose challenges for many individuals as…
Smart insulin has emerged as a groundbreaking advancement in diabetes management, taking a significant leap forward in insulin therapy. This…
Sugar Defender Reviews: Scammy Blood Sugar Drops or Legit Solution? Everything You Need to Be Aware Of in 2024 Sugar…
Dexcom Launches First Over-the-Counter Continuous Glucose Monitor Dexcom, in a groundbreaking move for people living with diabetes, has launched the…
“Diabetes Prevention: Reducing Night Light Exposure as a Simple Solution” Diabetes, particularly type 2 diabetes, has become a global health…